Nexalin Technology, Inc. Investing Cash Flow
Nexalin Technology, Inc. (NXL) reported Investing Cash Flow of $2.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-12
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $1.46M.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $1.51M, a 2.44% increase year-over-year.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $689.18K, a 57.66% decline year-over-year.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $1.63M.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$131.99K.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$577.54K, a 112.97% decline from fiscal 2023.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $4.45M.
- Nexalin Technology, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$6.79M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.97M 10-Q · filed 2026-08-12 | $3.66M derived: sum of 3 quarters · filed 2026-08-12 | $5.28M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.51M 10-Q · filed 2026-05-08 | $2.20M derived: sum of 2 quarters · filed 2026-05-08 | $3.82M derived: sum of 3 quarters · filed 2026-05-08 | -$96.07K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $689.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.31M derived: sum of 2 quarters · filed 2026-03-25 | -$1.61M derived: sum of 3 quarters · filed 2026-08-12 | -$131.99K 10-K · filed 2026-03-25 |
| 2025-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.29M derived: sum of 2 quarters · filed 2026-08-12 | -$821.17K 10-Q · filed 2025-11-14 | $806.37K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.45M 10-Q · filed 2026-08-12 | -$818.64K derived: sum of 3 quarters · filed 2026-08-12 | -$5.30M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.47M 10-Q · filed 2026-05-08 | $3.10M derived: sum of 2 quarters · filed 2026-05-08 | -$1.38M derived: sum of 3 quarters · filed 2026-05-08 | $166.91K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$2.86M derived: sum of 2 quarters · filed 2026-03-25 | -$1.31M derived: sum of 3 quarters · filed 2026-03-25 | -$577.54K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.93M derived: sum of 2 quarters · filed 2025-11-14 | -$2.21M 10-Q · filed 2025-11-14 | -$982.22K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.28M 10-Q · filed 2025-08-06 | $3.50M derived: sum of 3 quarters · filed 2025-09-23 | $4.33M derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | $729.31K 10-Q · filed 2025-05-13 | $1.95M derived: sum of 2 quarters · filed 2025-09-23 | $2.78M derived: sum of 3 quarters · filed 2025-09-23 | $3.66M derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | $1.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | $2.05M derived: sum of 2 quarters · filed 2025-09-23 | $2.93M derived: sum of 3 quarters · filed 2025-09-23 | $4.45M 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $830.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.70M derived: sum of 2 quarters · filed 2024-11-08 | $3.23M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $872.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.40M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $1.53M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$6.79M 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |